The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

Two men are set to appear in federal court Friday after being arrested on charges of stealing and laundering $230 million in ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...

A new FTC report reveals major social media platforms, including Meta and TikTok, extensively surveil users for profit, ...

PBMs, like Optum Rx, are the key counterweight to pharmaceutical companies’ otherwise unchecked monopoly power to set and raise drug prices.

The Secret Service's leader said Friday the agency is instituting a "paradigm shift" in how it carries out its mission as it ...

Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, executive vice president and CEO of APhA, commended the Federal Trade Commission's (FTC) action today against alleged practices by large vertically ...

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.